Stay updated on Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2; the prior government-funding lapse notice and the Revision: v3.4.1 entry were removed.
    Difference
    0.4%
    Check dated 2026-02-11T02:18:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Notice: Added a government funding lapse banner and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T00:51:28.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated footer labels to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', along with the site revision updated to v3.4.0 (replacing v3.3.4).
    Difference
    0.2%
    Check dated 2026-01-28T00:20:12.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page metadata was updated: 'Type 2 diabetes' added with related topic 'MedlinePlus Genetics', and the page revision updated from v3.3.3 to v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-14T02:50:14.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    Type 2 diabetes and the related topics MedlinePlus Genetics were removed from the page's topics/MeSH section.
    Difference
    0.2%
    Check dated 2025-12-30T20:25:32.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Footer updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2; core study content and details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:21:15.000Z thumbnail image

Stay in the know with updates to Dapagliflozin Impact on T2DM Risk Factors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Impact on T2DM Risk Factors Clinical Trial page.